
Charanjit Aulakh
Examiner (ID: 2304, Phone: (571)272-0678 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1612, 1625, 1203, 1621 |
| Total Applications | 3771 |
| Issued Applications | 2863 |
| Pending Applications | 382 |
| Abandoned Applications | 583 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19564697
[patent_doc_number] => 12139458
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-12
[patent_title] => (2,5-dioxopyrrolidin-1-yl)(phenyl)-acetamide derivatives and their use in the treatment of neurological diseases
[patent_app_type] => utility
[patent_app_number] => 17/309956
[patent_app_country] => US
[patent_app_date] => 2020-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 15
[patent_no_of_words] => 16538
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 269
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17309956
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/309956 | (2,5-dioxopyrrolidin-1-yl)(phenyl)-acetamide derivatives and their use in the treatment of neurological diseases | Jan 6, 2020 | Issued |
Array
(
[id] => 16572185
[patent_doc_number] => 10894096
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-19
[patent_title] => 3,6,9, 15-tetraaza-bicyclo [9.3.1]pentadeca-1(14), 11(15), 12-triene based compounds and their application as ligands of essential metal ion based MRI and 52MN based PET contrast agents
[patent_app_type] => utility
[patent_app_number] => 16/736130
[patent_app_country] => US
[patent_app_date] => 2020-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8185
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16736130
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/736130 | 3,6,9, 15-tetraaza-bicyclo [9.3.1]pentadeca-1(14), 11(15), 12-triene based compounds and their application as ligands of essential metal ion based MRI and 52MN based PET contrast agents | Jan 6, 2020 | Issued |
Array
(
[id] => 16564199
[patent_doc_number] => 10889557
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-01-12
[patent_title] => Method of producing an alkoxyflavone derivative
[patent_app_type] => utility
[patent_app_number] => 16/727457
[patent_app_country] => US
[patent_app_date] => 2019-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2668
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16727457
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/727457 | Method of producing an alkoxyflavone derivative | Dec 25, 2019 | Issued |
Array
(
[id] => 16649959
[patent_doc_number] => 10927121
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-02-23
[patent_title] => Technologies for removing residual solvent from nalmefene hydrochloride and producing crystalline nalmefene hydrochloride monohydrate, monosolvate, or crystalline nalmefene hydrochloride dihydrate
[patent_app_type] => utility
[patent_app_number] => 16/723215
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 50
[patent_no_of_words] => 7946
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16723215
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/723215 | Technologies for removing residual solvent from nalmefene hydrochloride and producing crystalline nalmefene hydrochloride monohydrate, monosolvate, or crystalline nalmefene hydrochloride dihydrate | Dec 19, 2019 | Issued |
Array
(
[id] => 19961568
[patent_doc_number] => 12331052
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-17
[patent_title] => Organic compounds
[patent_app_type] => utility
[patent_app_number] => 17/417001
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24493
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17417001
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/417001 | Organic compounds | Dec 19, 2019 | Issued |
Array
(
[id] => 18232088
[patent_doc_number] => 11596632
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-07
[patent_title] => JAK1 pathway inhibitors for the treatment of gastrointestinal disease
[patent_app_type] => utility
[patent_app_number] => 16/720465
[patent_app_country] => US
[patent_app_date] => 2019-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 19
[patent_no_of_words] => 18367
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16720465
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/720465 | JAK1 pathway inhibitors for the treatment of gastrointestinal disease | Dec 18, 2019 | Issued |
Array
(
[id] => 16970400
[patent_doc_number] => 11066360
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-20
[patent_title] => Human plasma kallikrein inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/718537
[patent_app_country] => US
[patent_app_date] => 2019-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56688
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 425
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16718537
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/718537 | Human plasma kallikrein inhibitors | Dec 17, 2019 | Issued |
Array
(
[id] => 16081395
[patent_doc_number] => 20200194684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => PHOTOACTIVE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 16/712315
[patent_app_country] => US
[patent_app_date] => 2019-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5971
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16712315
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/712315 | Photoactive compound | Dec 11, 2019 | Issued |
Array
(
[id] => 15765773
[patent_doc_number] => 20200113904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => METHODS FOR TREATING HUNTINGTON'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/710515
[patent_app_country] => US
[patent_app_date] => 2019-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26351
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16710515
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/710515 | Methods for treating Huntington's disease | Dec 10, 2019 | Issued |
Array
(
[id] => 16246035
[patent_doc_number] => 10745375
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-18
[patent_title] => Adipate-type compounds and a process of preparing it
[patent_app_type] => utility
[patent_app_number] => 16/706036
[patent_app_country] => US
[patent_app_date] => 2019-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6344
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16706036
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/706036 | Adipate-type compounds and a process of preparing it | Dec 5, 2019 | Issued |
Array
(
[id] => 16328297
[patent_doc_number] => 20200299263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => ISOQUINOLIN-3-YL CARBOXAMIDES AND PREPARATION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/703321
[patent_app_country] => US
[patent_app_date] => 2019-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58662
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16703321
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/703321 | Isoquinolin-3-YL carboxamides and preparation and use thereof | Dec 3, 2019 | Issued |
Array
(
[id] => 16893136
[patent_doc_number] => 11034669
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-15
[patent_title] => Pyrrole and pyrazole compounds and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/698490
[patent_app_country] => US
[patent_app_date] => 2019-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25329
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16698490
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/698490 | Pyrrole and pyrazole compounds and methods of use thereof | Nov 26, 2019 | Issued |
Array
(
[id] => 16893136
[patent_doc_number] => 11034669
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-15
[patent_title] => Pyrrole and pyrazole compounds and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/698490
[patent_app_country] => US
[patent_app_date] => 2019-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25329
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16698490
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/698490 | Pyrrole and pyrazole compounds and methods of use thereof | Nov 26, 2019 | Issued |
Array
(
[id] => 16009013
[patent_doc_number] => 20200179349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => Methods of Treating Food Allergy Conditions
[patent_app_type] => utility
[patent_app_number] => 16/697670
[patent_app_country] => US
[patent_app_date] => 2019-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24253
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16697670
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/697670 | Methods of treating food allergy conditions | Nov 26, 2019 | Issued |
Array
(
[id] => 15681167
[patent_doc_number] => 20200095247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-26
[patent_title] => 4-AZAINDOLE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/695303
[patent_app_country] => US
[patent_app_date] => 2019-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65234
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16695303
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/695303 | 4-Azaindole compounds | Nov 25, 2019 | Issued |
Array
(
[id] => 18575480
[patent_doc_number] => 11731994
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-22
[patent_title] => Organometallic compound, organic light-emitting device including the organometallic compound, and diagnostic composition including the organometallic compound
[patent_app_type] => utility
[patent_app_number] => 16/695443
[patent_app_country] => US
[patent_app_date] => 2019-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 16590
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1879
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16695443
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/695443 | Organometallic compound, organic light-emitting device including the organometallic compound, and diagnostic composition including the organometallic compound | Nov 25, 2019 | Issued |
Array
(
[id] => 15649497
[patent_doc_number] => 20200087278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-19
[patent_title] => METHOD OF PREPARING N-ACYL ANTHRANILAMIDE
[patent_app_type] => utility
[patent_app_number] => 16/694989
[patent_app_country] => US
[patent_app_date] => 2019-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2267
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16694989
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/694989 | Method of preparing N-acyl anthranilamide | Nov 24, 2019 | Issued |
Array
(
[id] => 17356666
[patent_doc_number] => 20220017462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => ORTHO-PHTHALALDEHYDE CONTAINING LINKERS AND USE FOR PREPARATION OF ANTIBODY-DRUG CONJUGATE
[patent_app_type] => utility
[patent_app_number] => 17/296088
[patent_app_country] => US
[patent_app_date] => 2019-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17514
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17296088
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/296088 | ORTHO-PHTHALALDEHYDE CONTAINING LINKERS AND USE FOR PREPARATION OF ANTIBODY-DRUG CONJUGATE | Nov 20, 2019 | Abandoned |
Array
(
[id] => 15649573
[patent_doc_number] => 20200087316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-19
[patent_title] => PROCESS FOR PREPARING OXYCODONE HYDROCHLORIDE HAVING LESS THAN 25 PPM 14-HYDROXYCODEINONE
[patent_app_type] => utility
[patent_app_number] => 16/690052
[patent_app_country] => US
[patent_app_date] => 2019-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16619
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16690052
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/690052 | Process for preparing oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone | Nov 19, 2019 | Issued |
Array
(
[id] => 17281673
[patent_doc_number] => 11198693
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-14
[patent_title] => Functionalized heterocycles as antiviral agents
[patent_app_type] => utility
[patent_app_number] => 16/689448
[patent_app_country] => US
[patent_app_date] => 2019-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34830
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 461
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16689448
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/689448 | Functionalized heterocycles as antiviral agents | Nov 19, 2019 | Issued |